Tag:

Merck

Latest Headlines

Latest Headlines

Data in hand, Merck shoots for Keytruda approval for lung cancer

Hot on the heels of Bristol-Myers Squibb, Merck announced over the weekend that it has filed for FDA approval to market its PD-1 star Keytruda for non-small cell lung cancer.

Careful, European drugmakers. Fitch says M&A may be a bit too heated

Fitch Ratings is raising the flag on pharma M&A. The credit ratings agency says the current spate of dealmaking is putting some pressure on European Big Pharma players.

Merck takes its Ebola vaccine to Phase III in Sierra Leone

In the latest development in the race for an Ebola vaccine, Merck and partner NewLink have taken their candidate to late-stage trials in Sierra Leone, the companies announced Tuesday.

Merck's Frazier joins top-paid pharma CEOs with a $25M package

Thanks to a big stock grant, Merck & Co.'s Kenneth Frazier vaulted to the highest echelons of pharma CEO pay last year. With a pay package valued at more than $25 million, Frazier beat out Pfizer's Ian Read and Johnson & Johnson's Alex Gorsky--even if he fell far short of Regeneron chief Len Schleifer.

Merck R&D chief Perlmutter gets a big jump in compensation

When Roger Perlmutter exited an early "retirement" from Amgen to join Merck as head of R&D two years ago, he was going back to a company with one of the weakest R&D records in Big Pharma. One of his first chores was to execute a major restructuring, aimed at slimming down the pharma giant's multibillion-dollar R&D budget. And he simultaneously hit the accelerator on the PD-1 drug Keytruda, which won a pioneering FDA OK last year.

Merck finds buyer for 2nd Puerto Rico plant slated to close

Merck put two of three plants in Puerto Rico on a hit list in 2013 as part of its efforts to cut costs and headcount. But after selling one last year to Sanofi's animal health unit Merial, it has found a buyer for the second, efforts that together will have saved about 400 jobs on the island.

Chicago outbreak of dog flu has authorities pitching Merck vaccine

An outbreak of canine influenza in the Chicago area has affected 1,000 dogs, 5 of which died. The Cook County Department of Animal and Rabies Control is recommending that dog owners there obtain the canine influenza vaccine, which is made by Merck Animal Health.

Watch out for a two-front hep C price war when Merck's combo hits

Think we've seen a hepatitis C drug price war? Think again. This first round of pay-to-play formulary deals may pale in comparison to what's coming next year, as Merck & Co. gets closer to launching its two-drug combo pill.

Merck partially regains its breakthrough tag for hep C combo

Merck execs weren't happy when the FDA stripped its breakthrough therapy designation for their closely watched hepatitis C combo. But the agency has now relented--at least partly. The pharma giant said it's getting two new BTD titles in small subgroups of patients to replace the broader breakthrough tag that it lost.

UPDATED: Merck (sort of) wins back 'breakthrough' boasting rights on hep C

The FDA notified Merck execs last January that it was stripping away its breakthrough therapy designation for their closely watched hepatitis C combo. But the agency has now relented and reversed itself, in part, and the pharma giant today notes that it's getting two new BTD titles in narrow patient subpopulations to replace the broader one that it lost.